Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Programmed cell death 1 (PD‐1) blockade has rapidly emerged as an effective therapy for a wide variety of metastatic malignancies. It has been associated with multiple immune related adverse effects, including cutaneous eruptions. We describe two patients who developed clinical and histologic findings consistent with subacute cutaneous lupus erythematosus (SCLE) after receiving PD‐1 inhibitor therapy for metastatic lung cancer.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
